Treatments are more likely to be successful when you start them early rather than waiting to see if the symptoms get worse. Not every migraine episode has an aura. About one-quarter of people with ...

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

A migraine attack can be a debilitating condition. But a headache is just one part. There are other subtle warning symptoms to watch out for, neurologists say.

Functional medicine expert and naturopathic doctor, Dr. Alison Egeland, has launched Aura Functional Medicine, a new practice ...

The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

Unlike migraine patients with aura, which was characterized by distinct aura symptoms, migraine without aura (MWoA) patients lack such clear precursors, making its distinction from other migraine ...

Clinical trials demonstrated that a single dose of Symbravo provides rapid migraine relief, sustains efficacy for up to 48 ...

Millions of people around the globe are impacted by migraines every day. This neurological issue commonly results in headaches. However, its implications extend beyond discomfort. Knowledge about the ...

The risk of an ischemic stroke (when a clot blocks a blood vessel to the brain) is especially elevated for women with a history of migraine with aura. This, and various other risk factors, may play ...